IP Library Granted Patent US 11,938,126
Granted Patent B2
US 11,938,126 · App. 17/851,862 · Granted Mar 26, 2024

Method of treating diseases of the visual system

Inventor: Jonnie R. Williams (Sarasota, FL)
Assignee: MyMD Pharmaceuticals, Inc.
A61K31/465A61K8/4926A61K31/4439A61P3/08C07K14/4747Y02A50/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,938,126
App. No.
17/851,862
Granted
Mar 26, 2024
Kind
B2
Abstract

In some aspects, isomyosmine or a pharmaceutically acceptable salt thereof may be administered to an individual for the treatment of diseases of the visual system.

Claims (10)

1. A method of treating a disease of the visual system selected from the group consisting of uveitis, glaucoma, and age-related macular degeneration (AMD), the method comprising administering to an individual in need thereof a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable vehicle thereof.

2. The method of claim 1 , wherein the therapeutically effective amount is from about 0.001 to about 75 mg/kg/day.

3. The method of claim 1 , wherein the therapeutically effective amount is from about 0.01 to about 50 mg/kg/day.

4. The method of claim 1 , wherein the therapeutically effective amount is from about 0.1 to about 40 mg/kg/day.

5. The method of claim 1 , wherein the therapeutically effective amount is from about 1 to about 30 mg/kg/day.

6. The method of claim 1 , wherein the therapeutically effective amount is from about 1 to about 20 mg/kg/day.

7. The method of claim 1 , wherein the therapeutically effective amount is from about 1 to about 10 mg/kg/day.

8. The method of claim 1 , wherein the disease of the visual system is uveitis.

9. The method of claim 1 , wherein the disease of the visual system is glaucoma.

10. The method of claim 1 , wherein the disease of the visual system is age-related macular degeneration (AMD).

Assignments (2)
CHANGE OF NAME Recorded Jun 10, 2025
From: MYMD PHARMACEUTICALS, INC.
To: TNF PHARMACEUTICALS, INC.
Reel/Frame 071501/0834 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2022
From: WILLIAMS, JONNIE R.
To: MYMD PHARMACEUTICALS, INC.
Reel/Frame 060340/0590 →
Continuity (7)
Division 17524304 · Nov 11, 2021
Continuation 16928255 · Jul 14, 2020
Continuation In Part 16680677 · Nov 12, 2019
Continuation 15719875 · Sep 29, 2017
Continuation In Part PCTUS2016025126 · Mar 31, 2016
Provisional Application 62140618 · Mar 31, 2015
Related Publication 20220339147A1 · Oct 27, 2022